top of page

Viva Ventures Biotech Fund Completed $63M initial Closing for its USD Biotech Fund II

On March 31, 2021, Viva Ventures Biotech Fund announced its initial closing for its USD fund II. New LPs boarding on include several well-known and influential individual investors and family offices. They highly recognize Viva Ventures’ investment performance and expertise. Investing in the USD fund, they are willing to provide strategic support for the future fundraising and industrial resources for the development of portfolio companies. The total size of Viva Ventures Biotech Fund II is $100M. It has completed $63M in the initial closing.

Viva Ventures is one of the very few biotech VCs that have extensive expertise and industry know-how for early-stage investments.

Established in 2016, Viva Venture Fund I invested in 10 startups. Among the investments, four had exited successfully, including two exits through M&A and two through IPO. By the end of 2020, the TVPI of Fund I is more than 10X.  

 

Viva Ventures Biotech Fund II will keep on investing global first-in-class, discovery-stage biotech startups with significant growth potential, and helping them grow from 0 to 1, from idea to NewCo.

 

Marketing and investor relations:Zhichunwang@vivaventuresbiotech.com

Viva Ventures Biotech Fund Website: www.vivaventuresbiotech.com

This website is for informational purposes only and does not constitute an offer to sell, a solicitation to buy, or a recommendation for any security; nor does it constitute an offer to provide investment advisory or other services by Viva Ventures Biotech Fund or any of our affiliates. Nothing contained on the website constitutes investment advice or offers any opinion with respect to the suitability of any security, and the views expressed on this website should not be taken as advice to buy, sell, or hold any security or as an endorsement of any security or company. In preparing the information contained in this website, Viva Ventures Biotech has not taken into account the investment needs, objectives, and financial circumstances of any particular investor, and investments and companies referenced may not be suitable for all investors. Any views expressed on this website by Viva Ventures biotech were prepared based upon information, believed to be reliable, available to it at the time such views were written. Viva Ventures Biotech makes no guarantees as to their accuracy or completeness. All information is subject to change and may quickly become unreliable for various reasons, including changes in market conditions or economic circumstances. By accessing this website, the reader agrees that he/she not copy, reproduce, republish, upload, post, transmit, alter, or distribute in any way material from this website in any manner inconsistent with the purposes for which it is offered without the prior written consent of Viva Ventures Biotech.

bottom of page